Source: Health Products Regulatory Authority (IE) Revision Year: 2022 Publisher: Amdipharm Limited, Temple Chambers, 3 Burlington Road, Dublin 4, Ireland
Palmeux 25 mg prolonged-release suspension for injection in pre-filled syringe.
| Pharmaceutical Form |
|---|
|
Prolonged-release suspension for injection in pre-filled syringe. The suspension is white to off-white. The suspension is pH neutral (approximately 7.0). Osmolality 220-320 mOsm/Kg. |
Each pre-filled syringe contains paliperidone palmitate equivalent to 25 mg paliperidone.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Paliperidone |
Paliperidone is a selective blocking agent of monoamine effects, whose pharmacological properties are different from that of traditional neuroleptics. Even though paliperidone is a strong D2-antagonist, which is believed to relieve the positive symptoms of schizophrenia, it causes less catalepsy and decreases motor functions to a lesser extent than traditional neuroleptics. |
| List of Excipients |
|---|
|
Polysorbate 20 |
Pre-filled syringe (cyclic-olefin-copolymer) with a plunger stopper, backstop, and tip cap (chlorobutyl rubber) with a 22G 1½-inch safety needle and a 23G 1-inch safety needle.
Pack sizes: Pack contains 1 pre-filled syringe and 2 needles.
Amdipharm Limited, Temple Chambers, 3 Burlington Road, Dublin 4, Ireland
PA1142/040/001
Date of first authorisation: 4th March 2022
| Drug | Countries | |
|---|---|---|
| PALMEUX | Ireland |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
